Itraconazol-Loaded Nanostructured Lipid Carriers (NLC) for Pulmonary Application

J. PARDEIKE; S. WEBER; H. P. ZARFL; A. ZIMMER

doi:10.3797/scipharm.cespt.8.PNM14

You are currently viewing a new version of our website. To view the old version click .

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).

Conference Report

12 July 2010

Itraconazol-Loaded Nanostructured Lipid Carriers (NLC) for Pulmonary Application

and

Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology, Karl-Franzens Universität Graz, Universitätsplatz 1, 8010 Graz, Austria

Private Veterinary Sugery, Auen 23, 9400 Wolfsberg, Austria

Author to whom correspondence should be addressed.

Sci. Pharm.2010, 78(3), 684;https://doi.org/10.3797/scipharm.cespt.8.PNM14

Version Notes

Order Reprints

Abstract

Introduction: Aspergillosis is a common fungal infection in falcons. Standard treatment, systemic application of Itraconazol, is limited due to hepatotoxicity. [...]

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Effects of Mixing Mode on the Formation of Silica Nanoparticles Synthesized via Aqueous Sol-Gel Process

Spray Drying as a Novel Method for Producing Nanoparticles Intended for the Application in DPI's